Therefore, our study extends the current understanding of the alternative roles of cyclins in cell migration, identifying CCNE2 as a novel mediator of the migration of breast cancer cells and suggesting a wider role of cyclins in regulating the Hippo pathway. This evidence concerns the gene CCNE2 and breast carcinoma.